anrikefon [880]



anrikefon


SMILES CC(=O)N1CC2(CCN(C(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](N)Cc3ccccc3)CC2)C1
InChIKey VWXDZAZSCZVCPV-YFRBGRBWSA-N
Sequence FFLK

Chemical Properties

Hydrogen bond acceptors 7
Hydrogen bond donors 5
Rotatable bonds 17
Log P 1.900
Molecular weight (Da) 703.4
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

anrikefon


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.